Clinical Utility of SMBG: Recommendations on the Use and Reporting of SMBG in Clinical Research

Affiliations

• ¹ Forschergruppe Diabetes at the Helmholtz Center Munich, Munich, Germany oliver.schnell@lrz.uni-muenchen.de.
• ² Southampton General Hospital, University of Southampton, Southampton, U.K.
• ³ International Diabetes Center at Park Nicollet, Minneapolis, MN.
• ⁴ Vita-Salute San Raffaele University, Milan, Italy.
• ⁵ Department of Internal Medicine, University of Colorado at Denver and University of Colorado Health Sciences Center, Denver, CO.
• ⁶ Centre Hospitalier Universitaire Nancy, Vandoeuvre-Les-Nancy, France.
• ⁷ Diabetes Center Mergentheim, Bad Mergentheim, Germany.
• ⁸ University of Washington School of Medicine, Seattle, WA.
• ⁹ Department of Endocrinology and Metabolism, Peking University People's Hospital, Peking, China.
• ¹⁰ Indian Academy of Diabetes, Ahmedabad, India.
• ¹¹ Queensland University of Technology, Brisbane, Australia.
• ¹² Joslin Diabetes Center, Boston, MA.
• ¹³ University Hospital Gasthuisberg Leuven, Leuven, Belgium.
• ¹⁴ Behavioral Diabetes Institute, University of California, San Diego, San Diego, CA.
• ¹⁵ Department of Medical Psychology, VU University Medical Center and Academic Medical Center, Amsterdam, the Netherlands.
• ¹⁶ Institute of Cellular Medicine-Diabetes, Newcastle University, Newcastle upon Tyne, U.K.